Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts.

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMC 414793)

Published in Infect Immun on February 01, 1974

Authors

M W Cunningham, E H Beachey

Articles citing this

Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35

Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80

Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56

Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69

Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62

Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89

Streptococcus adherence and colonization. Microbiol Mol Biol Rev (2009) 2.83

Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77

Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18

Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1. Infect Immun (1992) 1.88

Location of the complement factor H binding site on streptococcal M6 protein. Infect Immun (1995) 1.44

Characterization of a non-type-specific antigen(s) associated with group A streptococcal type 12 M protein. Infect Immun (1975) 1.16

Type-specific opsonic antibodies in streptococcal pyoderma. Infect Immun (1974) 0.93

Beta haemolytic streptococci and reactive arthritis in adults. Ann Rheum Dis (1993) 0.87

Extraction of streptococcal type 12 M protein by cyanogen bromide. Infect Immun (1978) 0.84

Anti-Hsp65 antibodies recognize M proteins of group A streptococci. Infect Immun (1996) 0.82

[Recent progress in the fight against acute arthritic rheumatism and future perspectives: WHO Memorandum]. Bull World Health Organ (1979) 0.75

Recent advances in rheumatic fever control and future prospect: a WHO memorandum. Bull World Health Organ (1978) 0.75

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96

Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (1962) 18.89

IMPROVED TECHNIQUE FOR THE PREPARATION OF STREPTOCOCCAL CELL WALLS. J Bacteriol (1964) 4.99

An M-associated protein antigen (MAP) of group A streptococci. J Hyg (Lond) (1971) 3.05

New observations on the structure and antigenicity of the M proteins of the group A streptococcus. Immunochemistry (1969) 2.63

Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59

Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol (1969) 2.25

Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13

Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans. J Exp Med (1966) 1.89

Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74

A fibrinogen precipitating factor (FPF) of group A streptococci. Proc Soc Exp Biol Med (1959) 1.66

Enhancing effect of type specific antistreptococcal antibodies on emergence of streptococci rich in M-protein. Proc Soc Exp Biol Med (1967) 1.58

The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man. Trans Assoc Am Physicians (1972) 1.51

Prospects for a vaccine against group A streptococci: the problem of the immunology of M proteins. Arthritis Rheum (1967) 1.36

Collagen-induced platelet aggregation: involement of an active glycopeptide fragment (alpha1-CB5). Science (1973) 0.95

Articles by these authors

(truncated to the top 100)

Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis (1981) 14.19

Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22

Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97

Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99

Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55

Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med (1975) 5.30

Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40

Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J Infect Dis (1974) 4.15

Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62

Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38

Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11

The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J Bacteriol (1986) 2.93

Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89

Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun (1983) 2.85

Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84

Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med (1985) 2.61

Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59

Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med (1985) 2.53

Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun (1983) 2.48

Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest (1978) 2.40

Binding of group A streptococci to human oral mucosal cells by lipoteichoic acid. Trans Assoc Am Physicians (1975) 2.32

Myosin: a link between streptococci and heart. Science (1985) 2.28

Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol (1987) 2.26

Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol (1969) 2.25

Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (1988) 2.24

Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol (1982) 2.22

Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19

Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18

Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells. Infect Immun (1977) 2.17

Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13

Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin. J Clin Invest (1979) 2.10

Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03

Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J Exp Med (1980) 2.00

Induction of delayed hypersensitivity to influenza and mumps viruses in mice. J Immunol (1969) 1.99

Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99

Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. J Exp Med (1983) 1.96

Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J Bacteriol (1988) 1.86

Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J Exp Med (1983) 1.82

Bacterial adherence. Adv Intern Med (1980) 1.80

Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77

Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J Biol Chem (1980) 1.75

Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74

Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies. J Biol Chem (1983) 1.73

Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol (1973) 1.73

Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72

Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol (1975) 1.72

Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun (1985) 1.71

Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage (2000) 1.71

Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med (1986) 1.71

Superantigenicity of streptococcal M protein. J Exp Med (1990) 1.70

Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67

Hydrophobic interactions of group A streptococci with hexadecane droplets. J Bacteriol (1983) 1.67

Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis (1980) 1.67

Erythrocyte binding properties of streptococcal lipoteichoic acids. Infect Immun (1979) 1.65

Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65

Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65

Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med (1988) 1.63

Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J Bacteriol (1983) 1.63

Enzyme-linked immunosorbent assay for adherence of bacteria to animal cells. J Clin Microbiol (1986) 1.62

Common protective antigens of group A streptococcal M proteins masked by fibrinogen. J Exp Med (1984) 1.59

Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J Exp Med (1982) 1.59

Binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun (1986) 1.58

Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J Immunol (1986) 1.54

Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med (1982) 1.53

Interaction of human plasma fibronectin with cariogenic and non-cariogenic oral streptococci. Infect Immun (1983) 1.53

The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man. Trans Assoc Am Physicians (1972) 1.51

Postnatal development of binding of streptococci and lipoteichoic acid by oral mucosal cells of humans. J Infect Dis (1977) 1.50

Influence of sublethal concentrations of antibiotics on the expression of the mannose-specific ligand of Escherichia coli. Infect Immun (1980) 1.49

Lymphocytes binding and T cell mitogenic properties of group A streptococcal lipoteichoic acid. J Immunol (1979) 1.49

Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest (2000) 1.46

Comparison of the leader sequences of four group A streptococcal M protein genes. Nucleic Acids Res (1988) 1.44

Hyperadhesive mutant of type 1-fimbriated Escherichia coli associated with formation of FimH organelles (fimbriosomes). Infect Immun (1988) 1.44

Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies. Infect Immun (1984) 1.43

Sequence of myosin-crossreactive epitopes of streptococcal M protein. J Exp Med (1986) 1.43

Characterization of lipoteichoic acid binding to polymorphonuclear leukocytes of human blood. Infect Immun (1981) 1.43

Role of fibronectin in attachment of Streptococcus pyogenes and Escherichia coli to human cell lines and isolated oral epithelial cells. Infect Immun (1985) 1.41

A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol (1986) 1.37

Cloning and genetic analysis of serotype 5 M protein determinant of group A streptococci: evidence for multiple copies of the M5 determinant in the Streptococcus pyogenes genome. Infect Immun (1985) 1.37

Isolation and characterization of a receptor for type 1 fimbriae of Escherichia coli from guinea pig erythrocytes. J Biol Chem (1988) 1.34

Cell wall replication in Escherichia coli, studies by immunofluorescence and immunoelectron microscopy. J Bacteriol (1966) 1.33

Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis (2000) 1.31

Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med (1979) 1.30

Use of monoclonal antibodies to probe subunit- and polymer-specific epitopes of 987P fimbriae of Escherichia coli. Infect Immun (1987) 1.29

Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol (1989) 1.27

Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. Nucleotide sequences of monospecific anti-Haemophilus antibodies and polyspecific antibodies cross-reacting with self antigens. J Clin Invest (1993) 1.27

Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes. J Immunol (1987) 1.26

The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor. Infection (1982) 1.26

Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol (1989) 1.26

Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect Immun (1983) 1.25

Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides. Virus Res (1986) 1.24

Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvant. Biochem Biophys Res Commun (1983) 1.23

Oriented fragmentation of Escherichia coli sacculi by sonication. J Bacteriol (1980) 1.23

Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem. J Exp Med (1987) 1.23

Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med (1986) 1.22

Exoenzymatic activity of transglycosylase isolated from Escherichia coli. Eur J Biochem (1981) 1.21

Characteristics of the binding of streptococcal lipoteichoic acid to human oral epithelial cells. J Infect Dis (1980) 1.21

Identification of the substance binding pemphigus antibody and concanavalin A in the skin. J Invest Dermatol (1974) 1.20

Lipoteichoic acid and M protein: dual adhesins of group A streptococci. Microb Pathog (1992) 1.20

Relationship of critical micelle concentrations of bacterial lipoteichoic acids to biological activities. Infect Immun (1986) 1.19